Home/Filings/4/0001209191-13-036928
4//SEC Filing

MEI Pharma, Inc. 4

Accession 0001209191-13-036928

$LITSCIK 0001262104operating

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 1:20 PM ET

Size

5.6 KB

Accession

0001209191-13-036928

Insider Transaction Report

Form 4
Period: 2013-07-15
Zech Thomas M.
Chief Financial Officer
Transactions
  • Award

    Option to purchase shares of common stock

    2013-07-15+10,000121,000 total
    Exercise: $7.43Exp: 2018-07-15Common Stock par value $0.00000002 (10,000 underlying)
Footnotes (2)
  • [F1]One-quarter of the options will vest on July 15, 2014; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.
  • [F2]The total number of derivative securities reported in column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001262104

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 1:20 PM ET
Size
5.6 KB